Buckingham Strategic Wealth, LLC Amgen Inc Transaction History

Buckingham Strategic Wealth, LLC

  • $8.98 Billion
  • Q2 2024

A detailed history of Buckingham Strategic Wealth, LLC transactions in Amgen Inc stock. As of the latest transaction made, Buckingham Strategic Wealth, LLC holds 12,765 shares of AMGN stock, worth $3.7 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
12,765
Previous 13,016 1.93%
Holding current value
$3.7 Million
Previous $3.7 Million 7.78%
% of portfolio
0.04%
Previous 0.04%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024
SELL
$262.75 - $319.31 $65,950 - $80,146
-251 Reduced 1.93%
12,765 $3.99 Million
Q1 2024

May 09, 2024
SELL
$268.87 - $324.56 $1.15 Million - $1.39 Million
-4,283 Reduced 24.76%
13,016 $3.7 Million
Q4 2023

Feb 14, 2024
SELL
$255.7 - $288.46 $383,550 - $432,689
-1,500 Reduced 7.98%
17,299 $4.98 Million
Q3 2023

Nov 13, 2023
SELL
$218.65 - $271.46 $425,274 - $527,989
-1,945 Reduced 9.38%
18,799 $5.05 Million
Q2 2023

Aug 11, 2023
BUY
$214.27 - $253.37 $1.51 Million - $1.79 Million
7,061 Added 51.6%
20,744 $4.61 Million
Q4 2022

Feb 13, 2023
BUY
$229.03 - $291.01 $48,325 - $61,403
211 Added 1.57%
13,683 $3.59 Million
Q3 2022

Nov 07, 2022
SELL
$224.46 - $253.15 $316,713 - $357,194
-1,411 Reduced 9.48%
13,472 $3.04 Million
Q2 2022

Aug 12, 2022
SELL
$230.71 - $256.74 $2,076 - $2,310
-9 Reduced 0.06%
14,883 $3.62 Million
Q1 2022

May 10, 2022
BUY
$219.27 - $242.57 $63,807 - $70,587
291 Added 1.99%
14,892 $3.6 Million
Q4 2021

Feb 09, 2022
BUY
$198.88 - $227.6 $332,527 - $380,547
1,672 Added 12.93%
14,601 $3.29 Million
Q3 2021

Nov 10, 2021
BUY
$212.27 - $248.7 $88,728 - $103,956
418 Added 3.34%
12,929 $2.75 Million
Q2 2021

Aug 06, 2021
BUY
$233.58 - $259.14 $232,879 - $258,362
997 Added 8.66%
12,511 $3.05 Million
Q1 2021

Apr 30, 2021
SELL
$221.91 - $258.6 $785,783 - $915,702
-3,541 Reduced 23.52%
11,514 $2.87 Million
Q4 2020

Feb 16, 2021
BUY
$216.38 - $257.67 $838,688 - $998,728
3,876 Added 34.67%
15,055 $3.46 Million
Q3 2020

Nov 12, 2020
BUY
$234.65 - $260.95 $51,153 - $56,887
218 Added 1.99%
11,179 $2.84 Million
Q2 2020

Aug 03, 2020
SELL
$197.81 - $242.74 $1.47 Million - $1.8 Million
-7,412 Reduced 40.34%
10,961 $2.59 Million
Q1 2020

May 07, 2020
BUY
$182.24 - $241.7 $951,657 - $1.26 Million
5,222 Added 39.71%
18,373 $3.73 Million
Q4 2019

Feb 04, 2020
BUY
$189.21 - $243.2 $167,450 - $215,232
885 Added 7.22%
13,151 $3.17 Million
Q3 2019

Nov 12, 2019
BUY
$174.11 - $208.62 $14,973 - $17,941
86 Added 0.71%
12,266 $2.37 Million
Q2 2019

Aug 05, 2019
BUY
$166.7 - $195.41 $168,033 - $196,973
1,008 Added 9.02%
12,180 $2.24 Million
Q1 2019

May 02, 2019
BUY
$180.87 - $203.88 $81,210 - $91,542
449 Added 4.19%
11,172 $2.12 Million
Q4 2018

Feb 11, 2019
BUY
$178.4 - $208.25 $17,840 - $20,825
100 Added 0.94%
10,723 $2.09 Million
Q3 2018

Nov 02, 2018
SELL
$185.29 - $208.89 $547,531 - $617,269
-2,955 Reduced 21.76%
10,623 $2.2 Million
Q2 2018

Aug 13, 2018
BUY
$166.05 - $186.51 $1.02 Million - $1.15 Million
6,169 Added 83.26%
13,578 $2.51 Million
Q1 2018

May 14, 2018
SELL
$169.43 - $198.0 $533,873 - $623,898
-3,151 Reduced 29.84%
7,409 $1.26 Million
Q4 2017

Feb 12, 2018
BUY
$168.79 - $188.59 $119,672 - $133,710
709 Added 7.2%
10,560 $1.84 Million
Q3 2017

Nov 08, 2017
BUY
$167.29 - $191.0 $1.65 Million - $1.88 Million
9,851
9,851 $1.84 Million

Others Institutions Holding AMGN

# of Institutions
3,122
Shares Held
410M
Call Options Held
7.56M
Put Options Held
7.2M
View Full List

About AMGEN INC

AMGN Quotes by TradingView
  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $155B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Buckingham Strategic Wealth, LLC Portfolio

Follow Buckingham Strategic Wealth, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Buckingham Strategic Wealth, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Buckingham Strategic Wealth, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email